Do adverse histopathologic findings in colorectal cancer patients explain disparate outcomes?

Journal of the National Medical Association

Volumn 98, Issue 3, 2006, Pages 348-351

  Gray, Keith D ^b   Ballard, Billy R ^a   Washington, M Kay ^b   Belue, Rhonda ^a   Grady, William M ^b   Chapman, William C ^c   Stain, Steven C ^a,b,d  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Colorectal cancer; Disparities; Pathology; Race

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHI SQUARE TEST; CITY; COLORECTAL ADENOMA; COLORECTAL CANCER; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33644804502     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2000 Incidence. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2003.
2. Henschke UK, Leffall LD, Mason CH, et al. Alarming increase of the cancer mortality in the U.S. black population (1950-1967). Cancer. 1973;31:763-768.
3. Wudel LJ, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137:550-556.
4. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001;93:501-515.
5. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
6. Cooper GS, Zhong Y, Landefeld CS, et al. Surgery for colorectal cancer: Race related differences in rates and survival among Medicare beneficiaries. Am J Public Health. 1996;86:582-586.
7. Dominitz JA, Samsa GP, Landsman P, et al. Race, treatment and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998;82:2312-2320.
8. Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the national surgical adjuvant breast and bowel project. J Natl Cancer Inst. 1999;91:1933-1999.
9. Brawley OW, Freeman HP. Race and outcomes: is this the end of the beginning for minority health research? J Natl Cancer Inst. 1999;91:1908-1909.
10. Umbleby HC, Ranson DL, Williamson HC. Peculiarities of mucinous colorectal carcinoma. Br J Surg. 1985;72:715-718.
11. Grinnell RS. The grading and prognosis of carcinoma of the colon and rectum. Ann Surg. 1939;109:500-504.
12. Steinberg SM, Barkin JS, Kaplan RS, et al. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Group experience. Cancer. 1986;57:1866-1870.
13. Chapius PH, Dent OF, Bokey EL, et al. Adverse histopathological finding as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg. 2004;91:349-354.
14. Graham DM, Appleman HD. Crohn's like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol. 1990;3:332-335.
15. Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarters Prev. 1997;6:1087-1093.
16. Wong JH, Severino R, Honnebier MB, et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896-2900.